This brand name is authorized in Australia, Brazil, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug NEOTIGASON contains one active pharmaceutical ingredient (API):
1
|
UNII
LCH760E9T7 - ACITRETIN
|
|
Acitretin, a synthetic aromatic derivative of retinoic acid, has a favourable therapeutic ratio, with a greater and more specific inhibitory effect on psoriasis and disorders of epithelial keratinisation. The usual therapeutic response to acitretin consists of desquamation (with or without erythema) followed by more normal re-epithelialisation. Acitretin is the main active metabolite of etretinate. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D05BB02 | Acitretin | D Dermatologicals → D05 Antipsoriatics → D05B Antipsoriatics for systemic use → D05BB Retinoids for treatment of psoriasis |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 2019G, 2020H |
| BR | Câmara de Regulação do Mercado de Medicamentos | 537519120008517, 537519120008617, 537519120008717, 537519120008817 |
| EE | Ravimiamet | 1000731, 1834365, 1834376 |
| ES | Centro de información online de medicamentos de la AEMPS | 60302, 60303 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 414953, 456335, 456343, 581493 |
| GB | Medicines & Healthcare Products Regulatory Agency | 26781, 26782 |
| HK | Department of Health Drug Office | 39193, 39194 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-047281874, HR-H-770001325 |
| IE | Health Products Regulatory Authority | 19811, 28978, 55595, 61493 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 4540, 4541 |
| IT | Agenzia del Farmaco | 027480019, 027480021 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1001361, 1088897, 1090627, 1091059, 1093400 |
| MT | Medicines Authority | AA565/80401 |
| NL | Z-Index G-Standaard, PRK | 29866, 29874 |
| NZ | Medicines and Medical Devices Safety Authority | 5224, 5225 |
| PL | Rejestru Produktów Leczniczych | 100046826, 100046832 |
| SG | Health Sciences Authority | 08391P, 08392P |
| TN | Direction de la Pharmacie et du Médicament | 6993161, 6993162 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699638154777, 8699638154784 |
| ZA | Health Products Regulatory Authority | W/13.4.2/73, W/13.4.2/74 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.